Related Experiment Videos
Mapping genes encoding drug-metabolizing enzymes in recombinant inbred mice
J S Miles1, J E Moss, B A Taylor
1Imperial Cancer Research Fund, University Department of Biochemistry, Edinburgh, United Kingdom.
Genomics
|October 1, 1991
Summary
Genetic mapping identified new locations for key drug-metabolizing enzyme genes in mice. Restriction fragment length variants (RFLVs) helped pinpoint cytochrome P450IVA, glutathione S-transferases (GST), and UDP-glucuronyltransferase genes on specific chromosomes.
Area of Science:
- Genetics
- Molecular Biology
- Pharmacogenomics
Background:
- Drug metabolism is crucial for understanding drug efficacy and toxicity.
- Genetic variations in drug-metabolizing enzymes influence individual responses.
- Mouse models are essential for studying human genetic diseases and drug metabolism.
Purpose of the Study:
- To map the genetic loci of specific drug-metabolizing enzyme genes in mice.
- To identify restriction fragment length variants (RFLVs) for gene mapping.
- To establish the chromosomal locations of cytochrome P450IVA, glutathione S-transferases (GST), and UDP-glucuronyltransferase genes.
Main Methods:
- Utilized restriction fragment length variants (RFLVs) for genetic mapping.
- Employed probes for cytochrome P450IVA (P450IVA), alpha- and pi-class GST, and UDP-glucuronyltransferase (UDPGT-K39).
- Analyzed genetic differences between C57BL/6J and DBA/2J mouse strains.
Main Results:
- Mapped P450IVA genes (Cyp4 alpha) to chromosome 4.
- Located GST alpha genes to chromosome 9 and GST pi genes to chromosome 1.
- Identified UDPGT-K39 variants on chromosome 1 and an unidentifed chromosome.
Conclusions:
- Established precise chromosomal locations for several important drug-metabolizing enzyme genes in mice.
- These findings provide a foundation for further genetic and functional studies of drug metabolism.
- The identified RFLVs serve as valuable markers for future genetic research.